V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280011911 | 280006089 | 1.73 | 72 | Palliative (P) | 2014-12-29 | 2015-02-14 | Cisplatin+Gemcitabine (gallbladder) | N | null | 280029076 | CISPLATIN + GEMCITABINE |
| 280011912 | 280011937 | null | 57.9 | Palliative (P) | null | 2018-03-03 | Doxorubicin + Ifosfamide | null | null | 280029101 | DOXORUBICIN + IFOSFAMIDE |
| 280011913 | 280006103 | 1.84 | 81.7 | Palliative (P) | 2017-06-24 | 2017-06-29 | BUSULFAN + MELPHALAN | 02 | N | 280029119 | CETUXIMAB + IRINOTECAN |
| 280011914 | 280006105 | null | 66.3 | Palliative (P) | 2016-01-06 | 2016-12-05 | Capecitabine + Cisplatin | 2 | N | 280029120 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280011915 | 280006174 | 1.77 | 61 | Adjuvant (A) | 2017-12-10 | 2017-12-18 | LIPOSOMAL DOXORUBICIN | N | N | 280029421 | CARBOPLATIN + CETUXIMAB + FU |
| 280011916 | 280006187 | 1.65 | null | Palliative (P) | 2014-05-25 | 2014-06-06 | Cyclophosphamide PO +Vinorelbine IV | 02 | N | 280029448 | CARBOPLATIN + CETUXIMAB + FU |
| 280011917 | 280006195 | 1.69 | 115 | Palliative (P) | 2017-09-08 | 2019-01-16 | CARBOPLATIN + FLUOROURACIL | 02 | N | 280029471 | MITOMYCIN INTRAVESICULAR |
| 280011918 | 280006213 | 1.85 | 79.7 | Disease modification (D) | 2017-12-16 | 2017-12-16 | EpSSG NRSTS 2005 | N | N | 280029556 | EURAMOS TRIAL |
| 280011919 | 280006218 | null | 52.2 | Palliative (P) | 2015-01-04 | 2015-02-20 | VIDE | 02 | N | 280029560 | ERLOTINIB |
| 280011920 | 280009266 | 1.7 | 93 | Palliative (P) | 2019-01-20 | 2019-01-27 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 280029642 | GEDDIS TRIAL |
| 280011921 | 280006252 | 1.72 | 83.95 | Palliative (P) | 2018-10-18 | 2018-10-31 | Cyclophosphamide PO +Vinorelbine IV | N | N | 280029691 | FLUOROURACIL + MITOMYCIN |
| 280011922 | 280010725 | 1.71 | 86.3 | Curative (C) | 2016-08-17 | 2016-08-20 | VIDE | N | N | 280029727 | CARBO + FLUOROURACIL |
| 280011923 | 280010729 | null | null | Curative (C) | 2018-08-12 | 2018-09-26 | STS Rhabdo VIT0910 Vinc Irinotecan | 2 | N | 280029779 | CAPECITABINE + OXALIPLATIN |
| 280011924 | 280006283 | 1.83 | 97.3 | Palliative (P) | 2017-05-31 | 2017-06-04 | Bevacizumab + Cape + Oxali 14day | null | N | 280029782 | CARBO + FLUOROURACIL |
| 280011925 | 280006321 | 1.76 | 65 | null | 2019-07-24 | 2019-10-12 | EpSSG NRSTS 2005 | N | N | 280029958 | NIVOLUMAB |
| 280011926 | 280006326 | 1.67 | 72.5 | Curative (C) | null | 2017-08-18 | Mitomycin Intravesical | Y | null | 280029968 | FLUOROURACIL + MITOMYCIN |
| 280011927 | 280006329 | 1.73 | 70 | Palliative (P) | 2018-12-20 | 2019-02-11 | Cyclophosphamide PO +Vinorelbine IV | N | N | 280029973 | CISPLATIN + TOPOTECAN |
| 280011928 | 280006337 | 1.85 | 75.75 | Curative (C) | 2014-06-27 | 2014-07-18 | LANREOTIDE | 1 | null | 280030003 | NIVOLUMAB |
| 280011929 | 280006346 | 1.8 | 59.6 | Palliative (P) | 2018-10-10 | 2018-10-11 | GEMCARBO | N | N | 280030037 | CAPECITABINE + CARBOPLATIN |
| 280011930 | 280006350 | 1.77 | 56.7 | Curative (C) | 2019-11-15 | 2019-11-20 | IVADo | Y | N | 280030055 | CISPLATIN + FLUOROURACIL + RT |
| 280011931 | 280006367 | 1.68 | 48.3 | Palliative (P) | 2017-12-01 | 2017-12-19 | Cyclophosphamide + Topotecan | null | N | 280030073 | VINCRISTINE |
| 280011933 | 280006392 | 1.63 | 60.3 | Palliative (P) | null | 2018-06-08 | VIDE | N | N | 280030163 | CISPLATIN + DOXORUBICIN |
| 280011934 | 280010757 | 1.52 | 92 | Palliative (P) | 2019-07-24 | 2019-09-08 | CARBOPLATIN + CETUXIMAB | 2 | N | 280030165 | CISPLATIN + FLUOROURACIL + RT |
| 280011935 | 280006413 | 1.84 | 92 | Disease modification (D) | 2017-05-18 | 2017-06-07 | OCTREOTIDE | 02 | N | 280030190 | CARBO + FLUOROURACIL |
| 280011936 | 280006422 | 1.7 | 23.3 | Palliative (P) | 2014-04-20 | 2014-05-18 | CISPLATIN + FLUOROURACIL + RT | 01 | Y | 280030215 | DABRAFENIB + TRAMETINIB |
| 280011937 | 280006440 | null | 72 | Palliative (P) | 2018-12-20 | 2019-01-04 | Gemcitabine + Capecitabine | null | null | 280030268 | PAZOPANIB |
| 280011938 | 280006467 | 1.61 | 6.2 | Disease modification (D) | 2017-10-14 | 2017-10-18 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280030339 | VIDE |
| 280011939 | 280006480 | 1.73 | 96.5 | Palliative (P) | 2018-10-12 | 2019-04-08 | CISPLATIN + FLUOROURACIL + RT | N | N | 280030373 | THALIDOMIDE |
| 280011940 | 280006487 | null | 94 | Disease modification (D) | 2018-05-28 | 2018-06-09 | Cyclophosphamide High Dose | N | Y | 280030387 | CAPECITABINE + CARBOPLATIN |
| 280011941 | 280006510 | null | 93 | Palliative (P) | 2014-01-07 | 2014-02-21 | Capecitabine | N | N | 280030483 | AXITINIB |
| 280011942 | 280006517 | 1.8 | 41.5 | Palliative (P) | 2017-10-19 | 2018-04-24 | Rituximab | 02 | N | 280030509 | VINORELBINE |
| 280011943 | 280006530 | 1.91 | 51.4 | Palliative (P) | 2017-07-26 | 2018-01-30 | TRASTUZUMAB | N | N | 280030568 | MELPHALAN |
| 280011944 | 280006558 | 1.81 | 68 | Palliative (P) | 2018-04-02 | 2018-04-02 | Imatinib 400mg | 02 | N | 280030686 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280011945 | 280009416 | 1.8 | 108 | Palliative (P) | 2019-09-11 | 2019-09-13 | BEP 5 Day | N | N | 280030702 | ICE |
| 280011946 | 280006573 | 1.63 | 76.6 | Palliative (P) | 2019-01-11 | 2019-01-21 | Pemetrexed | N | N | 280030705 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 280011947 | 280009425 | 1.63 | 57.65 | Palliative (P) | 2017-12-16 | 2017-12-16 | CAPECITABINE + OXALIPLATIN | 02 | null | 280030761 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280011948 | 280006604 | 1.65 | 66.5 | Curative (C) | 2017-02-19 | 2017-04-23 | Capecitabine + Oxaliplatin 21day | 02 | N | 280030812 | CETUXIMAB + IRINOTECAN |
| 280011949 | 280006622 | 1.62 | null | Palliative (P) | 2016-02-01 | 2016-02-05 | TRASTUZUMAB | Y | N | 280018042 | CISPLATIN + FLUOROURACIL + RT |
| 280011950 | 280006629 | 1.62 | 74.5 | Palliative (P) | null | 2018-12-04 | STREPTOZOCIN | null | null | 280019073 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280011951 | 280006655 | 1.76 | 89.8 | Disease modification (D) | 2015-12-14 | 2015-12-29 | Carboplatin + Cetux + FU (Cycle 1) | N | N | 280020096 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280011952 | 280006662 | null | 63.75 | Palliative (P) | 2016-06-12 | 2016-06-15 | Cisplatin + Etoposide po&iv 3 day | N | N | 280020449 | VIDE |
| 280011953 | 280009462 | 1.64 | 80.5 | null | 2018-11-20 | 2018-11-21 | MELPHALAN | null | null | 280020669 | CAPECITABINE + CARBOPLATIN |
| 280011954 | 280010824 | 1.67 | 71.2 | Neo-adjuvant (N) | null | 2015-09-20 | Cyclophosphamide PO +Vinorelbine IV | N | N | 280023280 | CISPLATIN + VINORELBINE |
| 280011955 | 280006782 | 1.6 | 85 | Palliative (P) | null | 2017-02-27 | Liposomal Doxorubicin 40mg/m2 | N | N | 280023786 | NIVOLUMAB |
| 280011956 | 280010840 | 1.52 | 61.6 | Curative (C) | 2019-07-26 | 2019-08-16 | CISPLATIN + FLUOROURACIL + RT | 2 | N | 280026551 | VIDE |
| 280011957 | 280004144 | 1.83 | 63 | Curative (C) | 2014-12-30 | 2015-01-06 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 280000089 | CISPLATIN + RT |
| 280011959 | 280008298 | 1.77 | 93.6 | Curative (C) | 2018-09-28 | 2018-10-23 | Cisplatin + Radiotherapy | 01 | N | 280007377 | CISPLATIN + RT |
| 280011960 | 280004263 | 1.68 | 60.3 | Not known (9) | 2017-04-18 | 2017-04-18 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 280007383 | CISPLATIN + RT |
| 280011961 | 280004383 | 1.65 | 75.2 | Palliative (P) | 2014-09-12 | 2014-11-01 | Trabectedin | 02 | N | 280011597 | TRABECTEDIN |
| 280011962 | 280004401 | 1.69 | 80.4 | Disease modification (D) | 2018-06-19 | 2018-11-03 | Trial Unspecified | 02 | Y | 280011722 | TRIAL |